Comparing Ethema Health (OTCMKTS:GRST) & Oncology Institute (NASDAQ:TOI)

Oncology Institute (NASDAQ:TOI) and Ethema Health (OTCMKTS:GRST) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, valuation, risk, earnings and profitability.

Institutional & Insider Ownership

36.9% of Oncology Institute shares are owned by institutional investors. 8.5% of Oncology Institute shares are owned by insiders. Comparatively, 55.8% of Ethema Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Valuation & Earnings

This table compares Oncology Institute and Ethema Health”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Oncology Institute	$502.73 million	0.67	-$60.61 million	($0.56)	-6.13
Ethema Health	$6.02 million	0.13	-$2.06 million	N/A	N/A

Ethema Health has lower revenue, but higher earnings than Oncology Institute.

Analyst Ratings

This is a summary of current ratings and recommmendations for Oncology Institute and Ethema Health, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Oncology Institute	1	0	4	0	2.60
Ethema Health	0	0	0	0	0.00

Oncology Institute presently has a consensus target price of $7.00, indicating a potential upside of 104.08%. Given Oncology Institute’s stronger consensus rating and higher possible upside, equities research analysts clearly believe Oncology Institute is more favorable than Ethema Health.

Risk & Volatility

Oncology Institute has a beta of 0.17, meaning that its share price is 83% less volatile than the S&P 500. Comparatively, Ethema Health has a beta of 1.57, meaning that its share price is 57% more volatile than the S&P 500.

Profitability

This table compares Oncology Institute and Ethema Health’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Oncology Institute	-11.45%	N/A	-33.70%
Ethema Health	-9.35%	N/A	-5.77%

Summary

Oncology Institute beats Ethema Health on 6 of the 11 factors compared between the two stocks.

About Oncology Institute

The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services. The company also provides managing clinical trials, palliative care programs, stem cell transplants services, and other care delivery models associated with non-community-based academic and tertiary care settings; and conducts clinical trials for a range of pharmaceutical and medical device companies. It serves adult and senior cancer patients. The company has a strategic collaboration with Healthly Forge to offer cancer care services to patients in Southern California. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.

About Ethema Health

Ethema Health Corporation operates behavioral healthcare space specifically in the treatment of substance use disorders. It offers rehabilitation services. The company was formerly known as GreeneStone Healthcare Corporation and changed its name to Ethema Health Corporation in April 2017. Ethema Health Corporation is based in West Palm Beach, Florida.